XORTX Therapeutics (XRTX) Times Interest Earned (2020 - 2023)
XORTX Therapeutics' (XRTX) quarterly Times Interest Earned came in at -$982.7 in Q1 2023, up 9.4% YoY from -$898.25 in Q1 2022, and down 3350.92% on a QoQ basis from -$28.48 in Q4 2022.
XORTX Therapeutics (XRTX) Times Interest Earned (2020 - 2023) Analysis & Trends
XORTX Therapeutics (XRTX) has 4 years of Times Interest Earned data on file, last reported at -$982.7 in Q1 2023.
- Quarterly Times Interest Earned rose 9.4% year-over-year to -$982.7 in Q1 2023, while the trailing twelve-month figure through Mar 2026 was $1052142055.5 billion (up 140.12% YoY) and the FY2025 annual result came in at -$62.44, down 138.52% from the prior year.
- Times Interest Earned retreated to -$982.7 in Q1 2023, from -$28.48 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $1302.4 in Q2 2021 to a low of -$1084.7 in Q1 2022.
- A 4-year average of $55.79 and a median of -$24.87 in 2022 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 87.71% in 2022, down 364.31% in 2022.
- Tracing XRTX's Times Interest Earned over 4 years: stood at $584.84 in 2020, then slumped by 139.63% to -$231.77 in 2021, then soared by 87.71% to -$28.48 in 2022, then tumbled by 3350.92% to -$982.7 in 2023.
- The last three Times Interest Earned figures came in at -$982.7 (Q1 2023), -$28.48 (Q4 2022), and -$24.87 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -14.59 |
| Mar 31, 2023 | -982.70 |
| Dec 31, 2022 | -28.48 |
| Sep 30, 2022 | -24.87 |
| Jun 30, 2022 | -81.50 |
| Mar 31, 2022 | -1,084.69 |
| Dec 31, 2021 | -231.77 |
| Sep 30, 2021 | 293.96 |
| Jun 30, 2021 | 1,302.42 |
| Mar 31, 2021 | 410.38 |
| Dec 31, 2020 | 584.84 |
| Sep 30, 2020 | 456.11 |